Water vs. IV: could a simple drink prevent kidney damage from CT dye?
NCT ID NCT07459413
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares drinking water to receiving IV fluids for preventing kidney injury caused by contrast dye used in CT scans. Researchers will enroll 198 emergency department patients with mild-to-moderate kidney disease. Participants will either drink water or get IV fluids before and after their scan, and their kidney function will be checked 48-72 hours later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Water (oral hydration)
- What this could lead to
- If successful, this could show that simply drinking water is as effective as IV fluids for protecting kidneys during CT scans, simplifying care.
- What could go wrong
- This is a small, early-stage trial (198 participants) and only tests a non-inferiority hypothesis. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gaziosmanpasa Training and Research Hospital
RECRUITINGIstanbul, Gaziosmanpasa, 34255, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?
- A new pill aims to slow kidney failure and save lives
- AI takes on kidney disease: a new model to forecast Who's at risk